Global /United Kingdom /Healthcare /Medical Devices /MHC

Fortis Frontier PLC

MHC

• LSE: MHC • Delayed

9GBX 0%

0.1136 USD

As of 15 June 2026, Fortis Frontier PLC has a market cap of $5.82M USD, ranking #43838 globally and #1001 in the United Kingdom. It ranks #3888 in the Healthcare sector, and #823 in the Medical Devices industry.

Global Rank

43838

Country Rank

1001

Sector Rank

3888

Industry Rank

823

Key Stats

Market Cap

$5.82MUSD

4.34M GBP

Enterprise Value

-$1.9MUSD

-1.42M GBP

EBITDA (TTM)

-$701.69KUSD

-525.0K GBP

Net Income (TTM)

-$2.18MUSD

-1.63M GBP

PB Ratio

0.8

Company Profile

Country (HQ)

United Kingdom

Sector

Healthcare

Industry

Medical Devices

CEO

Penelope McCormick open_in_new

Employees

Founded

2008

Website

fortisfrontier-ir.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-8.3%	18%	-16%	18%	10%	-43%	-55%	-87%

News

Markets

Exchange	Ticker	Price	Quotes
London Stock Exchange (LSE / LON) MIC: XLON PRIMARY	MHC MyHealthChecked PLC ISIN: GB00BN7K5L93 Shares Out.: Shares Outstanding: 51.852M¹ Shares Float: 38.113M² TV: TradingView: LSE: MHC SA: Stock Analysis: LON: MHC YF: Yahoo Finance: MHC.L GF: Google Finance: LON: MHC BA: Barron's: MHC MS: Morningstar: XLON: MHC	9 GBX	TV: TradingView: LSE: MHC SA: Stock Analysis: LON: MHC YF: Yahoo Finance: MHC.L GF: Google Finance: LON: MHC BA: Barron's: MHC MS: Morningstar: XLON: MHC

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Fortis Frontier PLC

Fortis Frontier PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. It is also involved in the development of an accompanying proprietary digital platform. The company was formerly known as MyHealthChecked PLC and changed its name to Fortis Frontier PLC in November 2025. Fortis Frontier PLC was incorporated in 2008 and is based in Cheltenham, the United Kingdom.

Similar Companies

Industry: Medical Devices (United Kingdom)

Name	Market Cap (USD) diff.	PE	Country
Smith & Nephew plc LSE: SN	$13.24B 9.88B GBP 227K%	21.8	United Kingdom
Convatec Group PLC LSE: CTEC	$5.69B 4.25B GBP 98K%	34.0	United Kingdom
LivaNova PLC NASDAQ: LIVN	$3.22B 55K%	-	United Kingdom
NovoCure Ltd. NASDAQ: NVCR	$1.38B 24K%	-	United Kingdom
Advanced Medical Solutions Group plc LSE: AMS	$723.95M 540.36M GBP 12K%	55.3	United Kingdom
Tristel plc LSE: TSTL	$239.21M 178.54M GBP 4K%	22.9	United Kingdom

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 3M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 3M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 3M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 2M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 2M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 2M%	22.2	Ireland

chevron_leftBack